Literature DB >> 17249523

Regular alcohol drinking is a determinant of masked morning hypertension detected by home blood pressure monitoring in medicated hypertensive patients with well-controlled clinic blood pressure: the Jichi Morning Hypertension Research (J-MORE) study.

Joji Ishikawa1, Kazuomi Kario, Kazuo Eguchi, Masato Morinari, Satoshi Hoshide, Shizukiyo Ishikawa, Kazuyuki Shimada.   

Abstract

Morning blood pressure (BP) level may play an important role in the pathogenesis of cardiovascular events; however, morning BP detected by home BP monitoring may remain uncontrolled in medicated hypertensive patients even when clinic BP is well controlled (masked morning hypertension: MMHT). We studied the determinants of MMHT in stably medicated hypertensive outpatients. In the Jichi Morning Hypertension Research (J-MORE) study, 969 consecutive hypertensive outpatients were recruited by 43 doctors in 32 different institutes. They had been under stable antihypertensive medication status at least for 3 months. Clinic BP was measured on 2 different days and self-measured BP monitoring was conducted twice consecutively in the morning and evening for 3 days. Four-hundred and five patients had well-controlled clinic BP (systolic BP [SBP]<140 mmHg and diastolic BP [DBP]<90 mmHg). Among them, 246 patients (60.7%) had MMHT (morning SBP > or =135 mmHg and/or DBP > or =85 mmHg). Compared with the patients with normal clinic BP and morning BP, the patients with MMHT had a significantly higher prevalence of regular alcohol drinkers (35.0% vs. 23.3%, p=0.012), a significantly higher number of antihypertensive drug classes (1.83 +/- 0.82 vs. 1.66 +/- 0.84, p = 0.04) and a significantly higher clinic BP level (SBP: 130.4 +/- 7.6 mmHg vs. 127.8 +/- 8.4 mmHg, p = 0.001; DBP: 75.5 +/- 7.6 mmHg vs. 73.6 +/- 7.6 mmHg, p = 0.013). In logistic regression analysis, independent determinants for MMHT were regular alcohol drinking (odds ratio [OR]: 1.76; 95% confidence interval [CI]: 0.99-3.12; p = 0.05) and higher-normal clinic BP (130/85 mmHg < clinic SBP/DBP < 140/90 mmHg) (OR: 1.60; 95% CI: 1.05-2.44; p = 0.03) after adjustment for confounding factors. The patients who both drank alcohol regularly and had a higher-normal clinic BP had 2.71 times higher risk for MMHT than those who did not drink alcohol regularly and had a relatively lower-normal clinic BP (<130/85 mmHg) (p < 0.01). In conclusion, regular alcohol drinking is an independent determinant for MMHT detected by home BP monitoring in medicated hypertensive patients with well-controlled clinic BP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17249523     DOI: 10.1291/hypres.29.679

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  8 in total

Review 1.  Unmasking masked hypertension: prevalence, clinical implications, diagnosis, correlates and future directions.

Authors:  J Peacock; K M Diaz; A J Viera; J E Schwartz; D Shimbo
Journal:  J Hum Hypertens       Date:  2014-02-27       Impact factor: 3.012

2.  Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association.

Authors:  Thomas G Pickering; Nancy Houston Miller; Gbenga Ogedegbe; Lawrence R Krakoff; Nancy T Artinian; David Goff
Journal:  Hypertension       Date:  2008-05-22       Impact factor: 10.190

Review 3.  Morning hypertension.

Authors:  Thomas G Pickering
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-03       Impact factor: 3.738

4.  Prevalence of masked hypertension in African Americans.

Authors:  Timothy R Larsen; Alehegn Gelaye; Barryton Waanbah; Hadeel Assad; Yara Daloul; Frances Williams; Michael Williams; Susan Steigerwalt
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-10-20       Impact factor: 3.738

5.  Morning hypertension in treated hypertensives: baseline characteristics and clinical implications.

Authors:  Ju-Hee Lee; Jang-Whan Bae; Jung Bae Park; Chang Gyu Park; Ho-Joong Youn; Dong Ju Choi; Young Keun Ahn; Joon-Han Shin; Se-Joong Rim; Jang-Ho Bae; Dong-Woon Kim
Journal:  Korean Circ J       Date:  2011-12-31       Impact factor: 3.243

6.  Comparison of the efficacy and safety of azilsartan with that of candesartan cilexetil in Japanese patients with grade I-II essential hypertension: a randomized, double-blind clinical study.

Authors:  Hiromi Rakugi; Kazuaki Enya; Kenkichi Sugiura; Yoshinori Ikeda
Journal:  Hypertens Res       Date:  2012-01-26       Impact factor: 3.872

7.  Insufficient control of morning home blood pressure in Japanese patients with hypertension associated with diabetes mellitus.

Authors:  Haruhito A Uchida; Yoshio Nakamura; Hisanao Norii; Masanobu Kaihara; Yoshihisa Hanayama; Ken-Ei Sada; Jun Wada; Kenichi Shikata; Hirofumi Makino
Journal:  J Diabetes Investig       Date:  2010-12-03       Impact factor: 4.232

8.  Effects of olmesartan-based treatment on masked, white-coat, poorly controlled, and well-controlled hypertension: HONEST study.

Authors:  Kazuomi Kario; Ikuo Saito; Toshio Kushiro; Satoshi Teramukai; Yusuke Ishikawa; Fumiaki Kobayashi; Kazuyuki Shimada
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-04-25       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.